Home/Filings/4/0001209191-19-003409
4//SEC Filing

Mallon Mark 4

Accession 0001209191-19-003409

CIK 0001446847other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:13 PM ET

Size

7.2 KB

Accession

0001209191-19-003409

Insider Transaction Report

Form 4
Period: 2019-01-09
Mallon Mark
DirectorChief Executive Officer
Transactions
  • Award

    Class A Common Stock

    2019-01-09+93,03693,036 total
  • Award

    Employee Stock Option (Right to Buy)

    2019-01-09+171,526171,526 total
    Exercise: $12.32Exp: 2029-01-09Class A Common Stock (171,526 underlying)
Footnotes (2)
  • [F1]The restricted stock unit award, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]The option, granted as a new hire award, vests as to 25% of the shares of Class A Common Stock on the first anniversary of January 4, 2019 and 1/48th of the shares of Class A Common Stock vest each month thereafter for the next 36 months.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001763533

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:13 PM ET
Size
7.2 KB